Quintet Private Bank (Europe)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$77.7K Sell
900
-2,400
-73% -$200K ﹤0.01% 138
2026
Q2
$222K Sell
3,300
-300
-8% -$20K 0.01% 105
2026
Q1
$226K Buy
3,600
+100
+3% +$6.96K 0.02% 105
2025
Q4
$232K Hold
3,500
– – 0.01% 105
2025
Q3
$236K Hold
3,500
– – 0.01% 106
2025
Q2
$306K Hold
3,500
– – 0.02% 97
2025
Q1
$239K Hold
3,500
– – 0.01% 109
2024
Q4
$272K Sell
3,500
-605
-15% -$44.8K 0.02% 105
2024
Q3
$275K Buy
4,105
+3,137
+324% +$258K 0.02% 103
2024
Q2
$125K Buy
+968
New +$122K 0.01% 134

Other funds holding DXCM

Quintet Private Bank (Europe)'s DXCM Position: Q3 2026 in Review

Quintet Private Bank (Europe) reduced its DexCom (DXCM) stake by 73% in Q3 2026, selling an estimated $200K and leaving 900 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #138.

Quintet Private Bank (Europe) first reported a position in DXCM in Q2 2024 and has held it in 10 quarters since. The position peaked at $306K in Q2 2025. 105 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Quintet Private Bank (Europe) held 900 shares of DexCom worth $77.7K as of Q3 2026.
  • Quintet Private Bank (Europe) sold 2,400 DexCom shares in Q3 2026, an estimated $200K.
  • DexCom made up ﹤0.01% of Quintet Private Bank (Europe)'s portfolio in Q3 2026, its #138 holding.
  • Quintet Private Bank (Europe) first reported a position in DexCom in Q2 2024 and has held it in 10 quarters since.
  • Quintet Private Bank (Europe)'s DexCom position peaked at $306K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2026, filed 8 Oct 2026.